Sarah Derubeis
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,793 and has fallen 93.8% since, to $111 in 2023.
Across 133 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$352
- Novo Nordisk$337
- AstraZeneca$181
- Gilead$125
- Lilly USA, LLC$125
- Takeda Pharmaceuticals U.S.A., Inc.$120
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,317100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $352 |
| Novo Nordisk | 18 | $337 |
| AstraZeneca | 13 | $181 |
| Gilead | 1 | $125 |
| Lilly USA, LLC | 12 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $120 |
| Viiv Healthcare Company | 1 | $111 |
| Boehringer Ingelheim | 6 | $109 |
| GSK | 6 | $106 |
| Amgen | 5 | $84 |
| Endo Pharmaceuticals Inc. | 5 | $80 |
| Biohaven Pharmaceuticals, Inc. | 4 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Pfizer | 4 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Johnson & Johnson(2 entities) | 3 | $50 |
| Fidia Pharma USA Inc. | 2 | $46 |
| Pacira Therapeutics, Inc. | 1 | $33 |
| Teleflex LLC | 1 | $27 |
| Alfasigma USA, Inc. | 2 | $26 |
| Lucid Diagnostics Inc. | 2 | $25 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| Abbott | 2 | $24 |
| Bioventus LLC | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,317 in reported general payments places this provider in the 80th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 32 | $1,312 |
Paid to pharmacies, not to this prescriber.
Other family in Mesa
- Sharon MagalonaMesa$441K
- Rebecca McCollaumMesa$149K
- Angela StuffMesa$22K
- Maria Norivic SorianoMesa$15K
- Kelly MatthewsMesa$15K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.